Optimi
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
269 David Brown Way, Princeton, British ...Phone Number
(778) 761-4551Website
www.optimi.netRevenue
<$5 MillionStock Symbol
OPTHIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Optimi
Optimi Health Corp. is a Canadian GMP-compliant pharmaceutical manufacturer licensed by Health Canada to produce and export MDMA and botanical psilocybin. Operating two 10,000 sq. ft. facilities in Princeton, BC under a Drug Establishment Licence, it supplies regulated psychedelic medicines to Australia's Authorised Prescribers Scheme for PTSD/treatment-resistant depression and supports clinical trials in Canada and Israel, while positioning for future U.S. market entry pending DEA rescheduling.Explore more
Optimi Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Optimi your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Optimi
Click to see if Optimi had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Optimi has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Optimi launches new products
Check out if Optimi is spiking on competitors!
Check if Optimi has recently received funding, and reach out quickly before it becomes old news!
Optimi, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Optimi recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Optimi is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Optimi is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Optimi.
Optimi financials insights
Gather financial insights about Optimi, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Debt
$2.2M
2024
Share Placement
$1.1M
Optimi Tech Stack
A closer look at the technologies used by Optimi
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Person-Based
Person-Based
Optimi News & Media
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
Supports Optimi’s planned Phase 2 psilocybin trial in major depressive disorder and Phase 3 MDMA trial in PTSD Supports Optimi’s planned Phase 2 psilocybin trial in major depressive disorder and Phase 3 MDMA trial in PTSDOptimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
Health Canada-authorized trial to evaluate efficacy and safety of two sessions of MDMA-assisted therapy in up to 100 veterans and frontline workers Health Canada-authorized trial to evaluate efficacy and safety of two sessions of MDMA-assisted therapy in up to 100 veterans and frontline workersOptimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
Health Canada-authorized trial to evaluate a single supervised dose of natural psilocybin, with dosing expected to be completed by the end of 2027Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
VANCOUVER, British Columbia, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Optimi Health Corp. (Nasdaq: OPTH) (CSE: OPTI) (“Optimi” or the “Company”), a commercial-stage pharmaceutical manufacturer of regulated psychedelic drug products, today announced that it will participate in the H.C. Wainwright 28th Annual Global Investment Conference. The conference will be held September 14-16, 2026, at the Lotte New York Palace Hotel.
Read more news
Top Manufacturing Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Optimi
Sign Up For FreeTo access detailed company insights
Optimi Health Corp. is a Canadian GMP-compliant pharmaceutical manufacturer licensed by Health Canada to produce and export MDMA and botanical psilocybin. Operating two 10,000 sq. ft. facilities in Princeton, BC under a Drug Establishment Licence, it supplies regulated psychedelic medicines to Australia's Authorised Prescribers Scheme for PTSD/trea... Read More
